You should re-think your investment thesis.
Given that it has been clearly stated by BOT and many others, the Rosacea trials are not only to meet primary end points, but also to prove safety and efficacy of a higher dosed formula. (As seen in the BTX1801 trials, higher dosage = greater efficacy).
This will then be a catalyst for further development for BTX1801 and BTX1503.
These trails are strategically placed to benefit the end goal.
Please stop thinking that management are backing a 50/50 bet on these trails.
Stay calm, accumulate while you can as I am doing.
*Not financial advice, DYOR, etc, etc
You should re-think your investment thesis.Given that it has...
-
- There are more pages in this discussion • 7,376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.010(2.86%) |
Mkt cap ! $633.5M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.5¢ | 35.5¢ | $425.6K | 1.176M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 234476 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 96052 | 1 |
View Market Depth
| Last trade - 10.14am 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |